Showing posts with label NEET PG. Show all posts
Showing posts with label NEET PG. Show all posts

Tuesday, November 10, 2026

Adult vaccination remains low, elderly miss cover against flu, pneumonia and shingles

Adult vaccination remains low, elderly miss cover against flu, pneumonia and shingles 

10.11.2026  TIMES BHOPAL

Anuja.Jaiswal@timesofindia.com New Delhi: 

Despite vaccines being available to prevent several infections that can be particularly serious for older people, adult immunisation remains low in India. Influenza, pneumococcal disease and shingles are among the key vaccine-preventable illnesses that pose a risk to older people, but studies point to poor awareness and low uptake of these vaccines. 

Ahead of World Immunisation Day Tuesday (Nov 10), the findings highlight a significant gap in protection beyond childhood. A multicentre study of 4,998 people aged 60 and above across Chennai, Ballabgarh, Kolkata and Pune found only 1.4% had ever received an influenza vaccine. While just 19.7% had heard of influenza, 35.9% considered vaccines safe and 65.3% were unwilling to pay for vaccination. 


However, uptake rose to 29.7% when vaccines were offered free of cost at community health camps. Published in ‘BMC Public Health’ in 2026, the study highlights gaps in awareness, acceptance and access to vaccination among older people. The disease burden is substantial. A separate study published in ‘Influenza and Other Respiratory Viruses’ in April 2026 estimated that influenza among Indians aged 60 and above accounted for 5.3 million respiratory infections, 36,149 hospitalisations and 84,613 deaths in 2021. 

The researchers found that an annual influenza vaccination programme for older adults could be cost-effective under most of the scenarios assessed. “Influenza and pneumococcal infections cause a significant burden among older Indians, accounting for an estimated 1.2 lakh deaths annually. Studies show that influenza vaccination can reduce influenza-associated pneumonia cases by 52% and deaths by 70%, while pneumococcal vaccination can lower hospitalisations by around 27% and deaths by 34%. 

Yet vaccination coverage among the elderly remains very low,” said Dr Neetu Jain, senior consultant, pulmonology, critical care and sleep medicine, PSRI Hospital. “Annual flu and pneumococcal vaccination is particularly important for people above 60 and those with COPD, asthma, diabetes or heart disease, as infections can lead to serious complications, including respiratory failure and prolonged hospitalisation,” she said. 

Evidence is also emerging of the economic value of pneumococcal vaccination. A study published in ‘Infectious Diseases and Therapy’ in Oct 2026 examined the cost-effectiveness of a single dose of the 20-valent pneumococcal conjugate vaccine (PCV20) for older adults and people at higher risk. It found that the vaccine could be a cost-effective option compared with existing vaccination approaches. Another infection of concern among older adults is shingles, caused by reactivation of the virus responsible for chicken pox. It can lead to prolonged nerve pain, known as postherpetic neuralgia. 

A 2026 paper in ‘Indian Journal of Community Medicine’ noted the lack of robust population-based data on shingles in India, while citing an estimate of around 45 lakh cases annually. An Indian phase-3 trial of the recombinant zoster vaccine, published in ‘Vaccine’ in 2025, reported an immune response in 85.7% of participants aged 50 and above. “Influenza and pneumococcal vaccines can reduce cases of severe illness, hospitalisation and complications, particularly among older people and those with chronic conditions such as diabetes, heart disease and COPD. 

Both are non-live vaccines and can be given to elderly people, including those with multiple conditions,” said Dr Jatin Ahuja, infectious disease specialist, Apollo Hospitals, Delhi. “India also needs to expand adult vaccination to cover shingles. The two-dose recombinant zoster vaccine is recommended for adults aged 50 and above and offers over 90% protection. Tdap or Td boosters, hepatitis B and, where indicated, Covid-19 and RSV vaccines should also be considered,” he said. Goa has taken a step towards expanding vaccination beyond childhood through its Lifecourse Immunisation Policy 2026-2036, launched in Sept. 

The policy identifies influenza, pneumococcal and hepatitis B vaccination among its priorities for elderly, those with chronic illnesses, immunocompromised individuals and healthcare workers. 

Monday, April 20, 2026

The NExT dilemma weighs patient safety against system readiness

The NExT dilemma weighs patient safety against system readiness

 Divyansh.Kumar@timesofindia.com 20.04.2026

TIMES OF INDIA EDUCATION TIMES BENGALURU

The National Medical Commission (NMC) has postponed the National Exit Test (NExT) for 2028-29, which has once again intensified the debate over the risks to the healthcare system when medical graduates enter practice without clearing a uniform competency test. 

After deferring its execution for five years in 2019, the NMC has again extended the dates of NExT implementation to ensure the system is adequately prepared for a nationwide rollout. NMC officials tell Education Times that NExT has been deferred as it is being redesigned. 

“NExT will help the NMC to bring standardised clinical training across the country by replacing final MBBS exams, NEET-PG and FMGE. The modalities are being worked out for the implementation, either immediately or phase-wise. The feedback from students, resident doctors, and faculty about having a common exam is good, but apprehensions exist about the final format,” said the source. 

To understand why this transition is critical, a MoHFW official explains that NExT is designed to serve a triple purpose: replacing the final-year university exams, substituting the NEET-PG entrance, and acting as a mandatory licentiate exam. “There are two lines of thought under discussion regarding the medical license. The first option is to separate the exam from the licensing process, where a student could pass the exam, obtain their degree, and pursue nonclinical careers without practising medicine. 

The second, more robust option links the license directly to the exam, you must pass it to practice. Ideally, it should be a unified, mandatory system for everyone,” the official says. The introduction of NExT will also lead to the scrapping of the Foreign Medical Graduate Examination (FMGE). “Whether it is an Indian medical graduate or those who studied in medical colleges in Russia, China, Iran or Philippines, everyone will ha-ve equal opportunity to take same exam,” the official adds. 

Currently, final-year MBBS exams are conducted independently by universities. NExT will replace this fragmented system, putting an en d to uneven university evaluations and addressing  the widespread issue of extortion in private institutions. “Because universities and colleges conduct their own practical exams, we receive complaints of private colleges demanding money from students, threatening to fail them in practicals,” the official says, adding, 

“A single, centralised exam will ensure absolute transparency. It will act as an automated quality control mechanism. Right now, we monitor ‘entry’ quality through NEET UG but lack a standardised way to check the quality of students ‘exiting’ the s ystem. A college that consistently produces students who pass NExT, proves it has good faculty.” Dr Rohan Krishnan, patron, FAIMA, says, “A high-stakes national exam cannot be fairly imposed on a country where clinical exposure and infrastructure vary across colleges.” FAIMA suggests initially using NExT as a formative assessment with no impact on licensure, follo-wed by full integration only after a nationwide audit of infrastructure and faculty. Kadwin Pillai, managing director, Trans world Educare, terms the rescheduling of NExT as a ‘pragmatic recalibration’ of India’s medical assessment strategy. 

“Rather than a simple delay, this period serves as an important buffer to move the system away from rote learning toward genuine clinical competence, ” Pillai says.

NEWS TODAY 21.11.2026